GSK plc Share Repurchase

On March 10, 2026, GSK plc executed a series of share repurchases, buying back a total of 505,000 ordinary shares at prices ranging from 2,052.00p to 2,082.00p, with a volume-weighted average price of 2,066.69p per share. These repurchased shares are to be held as treasury shares. This activity is part of the company's ongoing buyback program, initiated under a non-discretionary agreement with BNP Paribas SA, announced on February 17, 2026. Since the program's inception, GSK has repurchased 8,177,000 ordinary shares. Following this latest transaction, the company now holds 248,068,094 shares in treasury, with 4,068,100,728 ordinary shares outstanding (excluding treasury shares). This figure serves as the denominator for shareholders calculating their notification requirements under the FCA's Disclosure Guidance and Transparency Rules. The shares held in treasury now represent 6.10% of the total voting rights.